STAT

SEPTEMBER 21, 2023

The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two partners formed a monopoly in order to drive up prices and boost their profits. Normally, the FTC sues the company that it believes has violated antitrust law. But this lawsuit is novel by also going after a private equity sponsor that it believes hatched the entire alleged scheme — and could serve as a warning to other private

Hospitals 363

Hospitals 363

Pharma Times

SEPTEMBER 21, 2023

The investment will support research into cancer treatments and diagnosis - News - PharmaTimes

160

160

STAT

SEPTEMBER 21, 2023

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice. Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision.

Diabetes 353

Diabetes 353

Pharma Times

SEPTEMBER 21, 2023

The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes

158

158

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

SEPTEMBER 21, 2023

When Sarah, a mother of two, was diagnosed with breast cancer in 2021 at the age of 43, she carefully considered where to go for care. She had been referred by her doctor to Beth Israel Deaconess Medical Center, where she received a mammogram and the cancer diagnosis. But Sarah, who asked that her last name not be used, ultimately chose the Dana-Farber Cancer Institute, wanting a place that was known for cancer treatment.

Chemotherapy 350

Chemotherapy Hospitals 350

STAT

SEPTEMBER 21, 2023

This week, the Coalition of Kaiser Permanente Unions is negotiating a new national contract with the health care giant. More than 75,000 Kaiser Permanente health care workers across the country have voted to authorize a strike if Thursday and Friday’s bargaining sessions do not end in an acceptable deal. If announced, the strike will affect the more than 12 million people served by Kaiser’s 39 hospitals and 715 medical offices in California, Colorado, Oregon, Washington, Hawaii, Ge

Hospitals 319

Hospitals 319

PharmaVoice

SEPTEMBER 21, 2023

Launched this month, Brixadi from Braeburn gives patients a new tool to overcome addiction.

130

130

STAT

SEPTEMBER 21, 2023

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed. In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease.

Drug Development 307

Drug Development 307

pharmaphorum

SEPTEMBER 21, 2023

The SPC waiver: How do we restore the intended balance between protection and innovation? Mike.

121

121

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

SEPTEMBER 21, 2023

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them.

299

299

pharmaphorum

SEPTEMBER 21, 2023

Smartphone app cuts racial disparity in post-birth care Phil.

119

119

STAT

SEPTEMBER 21, 2023

The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. The winners of the 2023 awards, announced on Thursday in New York, distinguished themselves in AI-enabled protein modeling, groundbreaking eye test technology, and in a wide-ranging career in medical science that combined innovative discoveries with attention to m

296

296

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. To establish it, the Novo Nordisk Foundation is committing up to £127 million. CEO of the Novo Nordisk Foundation Cellerator, Thomas HR Carlsen, told EPR that for cell therapy manufacturing, “The biggest challenge is producing high-quality, consistent cell therapies at the scale required for use in clinical trials… biological complexity [of living cells] means that the man

Hospitals 116

Hospitals 116

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

SEPTEMBER 21, 2023

WASHINGTON — In a striking display of discord Thursday, leaders of the Senate’s health committee clashed over a proposal to increase the number of primary care doctors and nurses in the United States. In drafting the policy, Chair Bernie Sanders (I-Vt.) circumvented Sen. Bill Cassidy (R-La.), the Republican leader on the panel. He instead negotiated with a lower-ranked Republican on the committee to produce the legislation, which Cassidy then refused to support.

Hospitals 286

Hospitals 286

Pharmaceutical Technology

SEPTEMBER 21, 2023

The US FDA has accepted Takeda’s NDA resubmission for TAK-721 for the short-term treatment of eosinophilic esophagitis (EoE), for review.

116

116

STAT

SEPTEMBER 21, 2023

Thermo Fisher Scientific’s  giant plant to manufacture gene therapies for drug companies  is barely a year old, but executives at the maker of scientific tools are already talking about expanding. Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories.

267

267

The Pharmacist

SEPTEMBER 21, 2023

The UK Government has announced funding of up to £103.5m for the development of affordable new vaccines to combat infectious diseases in developing countries. The investment – which will be made through the UK Vaccine Network – was announced along with a number of other measures by a government delegation at the UN General Assembly […] The post Government commits over £100m to global vaccine development appeared first on The Pharmacist.

Vaccines 115

Vaccines 115

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

STAT

SEPTEMBER 21, 2023

You’re reading the web edition of D.C. Diagnosis.  Sign up here  to receive this newsletter in your inbox on Tuesdays and Thursdays. This could get ugly The Senate health committee is on a crash course today, as the panel considers a primary care and workforce bill that ranking member Bill Cassidy (R-La.) opposes. One sign of how messy it could get?

Drug Pricing 214

Drug Pricing Hospitals 214

pharmaphorum

SEPTEMBER 21, 2023

Roche inks pipeline deals with Orionis, PeptiDream Phil.

111

111

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new report published by the Center for Global Development (CGD) has highlighted the need for coordinated global action against antimicrobial resistance (AMR). Experts from organisations such as the Wellcome Trust and Africa Centres for Disease Control and Prevention contributed to the paper, urging governments, industry and international organisations to create a political agreement, or ‘Grand Bargain’, to improve innovation, access, and stewardship for antimicrobials, particularly in low- and

111

111

pharmaphorum

SEPTEMBER 21, 2023

Novo Nordisk Foundation pledges €127m for cell therapy plant Phil.

111

111

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

Competition watchdog probes claims of profiteering by US drugmaker in country where tuberculosis is biggest killer South Africa’s Competition Commission will investigate the American drugmaker Johnson & Johnson for the high price it has been charging for the tuberculosis medicine bedaquiline, as well as for extending its 20-year patent until 2027 to block cheaper generics from entering the country.

Drug Pricing 110

Drug Pricing 110

pharmaphorum

SEPTEMBER 21, 2023

Cancer Research UK earmarks £123m for Scottish R&D Phil.

111

111

World Pharma News

SEPTEMBER 21, 2023

At an Extraordinary General Meeting, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease of the share capital of Novartis AG in the amount of the share capital of Sandoz.

Biosimilars 108

Biosimilars 108

Express Pharma

SEPTEMBER 21, 2023

Nitika Pharmaceuticals Specialities, excipient manufacturing company, recently inaugurated its microcrystalline cellulose (*Tabcell) manufacturing plant at Butibori, Nagpur. The company informed that this is India’s largest microcrystalline cellulose manufacturing facility. The inauguration of this manufacturing plant was attended by eminent personalities like Nitin Gadkari – Minister Road Transport and Highways India.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Commerce

SEPTEMBER 21, 2023

Deal aims to provide diabetes treatment to patients across the continent.

Diabetes 105

Diabetes 105

Drug Patent Watch

SEPTEMBER 21, 2023

This chart shows the patent expirations for film dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from… The post Film dosed drug patent expirations by year appeared first on DrugPatentWatch - Make Better Decisions.

105

105

pharmaphorum

SEPTEMBER 21, 2023

Menarini brings oral SERD to Europe with Orserdu okay Phil.

105

105